Evoq Remedies Limited board approves 18:5 rights issue

The Board of Directors of Evoq Remedies Limited, in their meeting held on 7th November, 2022 at the Registered Office of the Company, which commenced at 3:00 P.M. and concluded at 5:30 P.M. has approved the Issue of 4,89,60,000 Equity Shares of face value of Rs. 10/- at par aggregating of Rs. 48,96,00,000/- to all existing members of the Company on rights ("Rights Issue") in the ratio of 18 equity shares for every 5 equity share held by the eligible equity shareholders in the Company as on record date.

The board approved formation of a Committee of Directors to decide matters relating to the Rights Issue ("Rights Issue Committee") which includes, to decide or alter the treatment to be given to fractional entitlements, if any to make any application to the regulatory authorities as may be required, determine the terms and conditions of the Right Issue including structure and timing of the issue.

Shares of Evoq Remedies Limited was last trading in BSE at Rs. 15.00 as compared to the previous close of Rs. 15.35. The total number of shares traded during the day was 16000 in over 4 trades.

The stock hit an intraday high of Rs. 15.00 and intraday low of 14.75. The net turnover during the day was Rs. 238800.00.

Source : Equity Bulls

Keywords

EvoqRemedies INE0JVD01011 Trading Distributors FundRaising RightsIssue 18For5